|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sano T, Coit DG, Kim HH, Roviello F,
Kassab P, Wittekind C, Yamamoto Y and Ohashi Y: Proposal of a new
stage grouping of gastric cancer for TNM classification:
International Gastric Cancer Association staging project. Gastric
Cancer. 20:217–225. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bbenik GA: Localization, physiological
significance and possible clinical implication of gastrointestinal
melatonin. Biol Signals Recept. 10:350–366. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Slominski AT, Zmijewski MA, Semak I, Kim
TK, Janjetovic Z, Slominski RM and Zmijewski JW: Melatonin,
mitochondria, and the skin. Cell Mol Life Sci. 74:3913–3925. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Slominski AT, Hardeland R, Zmijewski MA,
Slominski RM, Reiter RJ and Paus R: Melatonin: A cutaneous
perspective on its production, metabolism, and functions. J Invest
Dermatol. 138:490–499. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Slominski RM, Reiter RJ,
Schlabritz-Loutsevitch N, Ostrom RS and Slominski AT: Melatonin
membrane receptors in peripheral tissues: Distribution and
functions. Mol Cell Endocrinol. 351:152–166. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li T, Ni L, Zhao Z, Liu X, Lai Z, Di X,
Xie Z, Song X, Wang X, Zhang R and Liu C: Melatonin attenuates
smoking-induced hyperglycemia via preserving insulin secretion and
hepatic glycogen synthesis in rats. J Pineal Res. 64:e124752018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Y, Li S, Zhou Y, Meng X, Zhang JJ, Xu
DP and Li HB: Melatonin for the prevention and treatment of cancer.
Oncotarget. 8:39896–39921. 2017.PubMed/NCBI
|
|
9
|
Wei X, Qi Y, Jia N, Zhou Q, Zhang S and
Wang Y: Hyperbaric oxygen treatment sensitizes gastric cancer cells
to melatonin-induced apoptosis through multiple pathways. J Cell
Biochem. 119:6723–6731. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang S, Qi Y, Zhang H, He W, Zhou Q, Gui
S and Wang Y: Melatonin inhibits cell growth and migration, but
promotes apoptosis in gastric cancer cell line, SGC7901. Biotech
Histochem. 88:281–289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ordoñez R, Carbajo-Pescador S,
Prieto-Dominguez N, García-Palomo A, González-Gallego J and Mauriz
JL: Inhibition of matrix metalloproteinase 9 and nuclear factor
kappa B contribute to melatonin prevention of motility and
invasiveness in HepG2 liver cancer cells. J Pineal Res. 56:20–30.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Proietti S, Cucina A, Dobrowolny G,
D'Anselmi F, Dinicola S, Masiello MG, Pasqualato A, Palombo A,
Morini V, Reiter RJ and Bizzarri M: Melatonin downregulates MDM2
gene expression and enhances p53 acetylation in MCF-7 cells. J
Pineal Res. 57:120–129. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Cutando A, López Valverde A, De Vicente J,
Gimenez JL, Carcía IA and DE Diego RG: Action of melatonin on
squamous cell carcinoma and other tumors of the oral cavity
(Review). Oncol Lett. 7:923–926. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu H, Xu L, Wei JE, Xie MR, Wang SE and
Zhou RX: Role of CD4+CD25+ regulatory T cells
in melatonin-mediated inhibition of murine gastric cancer cell
growth in vivo and in vitro. Anat Rec (Hoboken). 294:781–788. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wang RX, Liu H, Xu L, Zhang H and Zhou RX:
Melatonin downregulates nuclear receptor RZR/RORγ expression
causing growth-inhibitory and anti-angiogenesis activity in human
gastric cancer cells in vitro and in vivo. Oncol
Lett. 12:897–903. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Song J, Ma SJ, Luo JH, Zhang H, Wang RX,
Liu H, Li L, Zhang ZG and Zhou RX: Melatonin induces the apoptosis
and inhibits the proliferation of human gastric cancer cells via
blockade of the AKT/MDM2 pathway. Oncol Rep. 39:1975–1983.
2018.PubMed/NCBI
|
|
17
|
Liu H, Jiang JH, Xu L, Gong X and Zhou RX:
Proliferation inhibition and apoptosis induction of melatonin in
mouse MFC progastric cells in vitro and in vivo. Chin J Anat.
42:794–799. 2011.
|
|
18
|
Patil AS, Sable RB and Kothari RM: An
update on transforming growth factor-β (TGF-β): Sources, types,
functionsand clinical applicability for cartilage/bone healing. J
Cell Physiol. 226:3094–3103. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pickup M, Novitskiy S and Moses HL: The
roles of TGFβ in the tumour microenvironment. Nat Rev Cancer.
13:788–799. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Proietti S, Cucina A, D'Anselmi F,
Dinicola S, Pasqualato A, Lisi E and Bizzarri M: Melatonin and
vitamin D3 synergistically down-regulate Akt and MDM2 leading to
TGFβ-1-dependent growth inhibition of breast cancer cells. J Pineal
Res. 50:150–158. 2011.PubMed/NCBI
|
|
21
|
Xu L, Liu H, Zhang H, Wang RX, Song J and
Zhou RX: Growth-inhibitory activity of melatonin on murine
foregastric carcinoma cells in vitro and the underlying molecular
mechanism. Anat Rec (Hoboken). 296:914–920. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Liang X, Liang X, Zeng J, Wang L, Shen L,
Ma X, Li S, Wu Y, Ma L, Ci X, et al: Histone demethylase RBP2
promotes malignant progression of gastric cancer through
TGF-β1-(p-Smad3)-RBP2-E-cadherin-Smad3 feedback circuit.
Oncotarget. 6:17661–17674. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tas F, Yasasever CT, Karabulut S, Tastekin
D and Duranyildiz D: Serum transforming growth factor-beta1 levels
may have predictive and prognostic roles in patients with gastric
cancer. Tumour Biol. 36:2097–2103. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li C, Song L, Zhang Z, Bai XX, Cui MF and
Ma LJ: MicroRNA-21 promotes TGF-β1-induced epithelial-mesenchymal
transition in gastric cancer through up-regulating PTEN expression.
Oncotarget. 7:66989–67003. 2016.PubMed/NCBI
|
|
26
|
Gen Y, Yasui K, Kitaichi T, Iwai N,
Terasaki K, Dohi O, Hashimoto H, Fukui H, Inada Y, Fukui A, et al:
ASPP2 suppresses invasion and TGF-β1-induced epithelial-mesenchymal
transition by inhibiting Smad7 degradation mediated by E3 ubiquitin
ligase ITCH in gastric cancer. Cancer Lett. 398:52–61. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhu J and Wen K: Astragaloside IV inhibits
TGF-β1-induced epithelial- mesenchymal transition through
inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
Phytother Re. 32:1289–1296. 2018. View
Article : Google Scholar
|
|
28
|
Ma HY, Liu XZ and Liang CM: Inflammatory
microenvironment contributes to epithelial-mesenchymal transition
in gastric cancer. World J Gastroenterol. 22:6619–6628. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gonzalez-Moreno O, Lecanda J, Green JE,
Segura V, Catena R, Serrano D and Calvo A: VEGF elicits
epithelial-mesenchymal transition (EMT) in prostate intraepithelial
neoplasia (PIN)-like cells via an autocrine loop. Exp Cell Res.
316:554–567. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wu Q, Hou X, Xia J, Qian X, Miele L,
Sarkar FH and Wang Z: Emerging roles of PDGF-D in EMT progression
during tumorigenesis. Cancer Treat Rev. 39:640–646. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Ma GF, Miao Q, Zeng XQ, Luo TC, Ma LL, Liu
YM, Lian JJ, Gao H and Chen SY: Transforming growth factor-β1 and
-β2 in gastric precancer and cancer and roles in tumor-cell
interactions with peripheral blood mononuclear cells in vitro. PLoS
One. 8:e542492013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Yu N, Sun YT, Su XM, He M, Dai B and Kang
J: Melatonin attenuates TGFβ1-induced epithelial-mesenchymal
transition in lung alveolar epithelial cells. Mol Med Rep.
14:5567–5572. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang XG, Meng Q, Qi FM and Yang QF:
Blocking TGF-β inhibits breast cancer cell invasiveness via
ERK/S100A4 signal. Eur Rev Med Pharmacol Sci. 18:3844–3853.
2014.PubMed/NCBI
|
|
34
|
Chatterjee A, Mukhopadhyay S, Tung K,
Patel D and Foster DA: Rapamycin-induced G1 cell cycle arrest
employs both TGF-β and Rb pathways. Cancer Lett. 360:134–140. 2015.
View Article : Google Scholar : PubMed/NCBI
|
